+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oral Solid Dosage Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 278 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934471
Description Jump to:
The global oral solid dosage contract manufacturing market is poised for remarkable expansion, as forecasted by the publisher. In 2024, this market reached a valuation of US$26.3 billion and is expected to surge at a CAGR of 7%, reaching an impressive US$41.7 billion by the end of 2031.

Immediate-Release Mechanism Takes Center Stage

Immediate-release mechanisms accounted for over 50% of the market in 2023. The growth can be attributed to increased R&D activities focused on enhancing oral solid dosage forms and the rise in long-term contract manufacturing partnerships between biotechnology companies and Contract Development and Manufacturing Organizations (CDMOs). In 2023, oral solid dosage contract manufacturing revenue made up approximately 12% of the global contract manufacturing market.

Opportunities Abound for Technological Advancements

During the forecast period, there are abundant opportunities for oral solid dosage contract manufacturing companies worldwide. They can concentrate on technological advancements in oral solid dosage forms to enhance stability, yield, bioavailability, and morphological characteristics. This includes the development of various forms such as enteric-coated, extended-release, and controlled release.

For instance, companies like Catalent are making strides with their GPEx Boost platform for cell-line development, aimed at achieving stable, high-yielding mammalian cell lines for biosimilars.

Consolidation and Flexible Business Models

Despite recent advancements, the market remains fragmented with numerous small CMOs, presenting an opportunity for consolidation. Streamlining and consolidation can lead to better operating margins and higher growth potential. Additionally, firms can adopt flexible business models to attract both large and small pharma and biotech companies.

Overcoming Regulatory Hurdles

One of the key challenges facing oral solid dosage contract manufacturers is strict approval criteria imposed by regulatory authorities. Small CDMOs without cutting-edge equipment are more susceptible to process errors, poor quality, and pricing issues. In developed countries, stringent regulations have led to a decline in small molecule approvals, impacting contract development and manufacturing demand.

Global Insights

  • U.S. Dominance:
Oral Solid Dosage Contract Manufacturing is prominent in the U.S. due to the country's advanced healthcare sector. The U.S. holds a significant share in North America's oral solid dosage contract manufacturing market, primarily because of the expansion of manufacturing facilities and a growing focus on drug discovery. Moreover, continuous advancements in the pharmaceutical industry and a rising demand for high-quality products have led many pharmaceutical companies to opt for Contract Manufacturing Organizations (CMOs) in the U.S.
  • China's Emergence: China is emerging as a prominent market for Oral Solid Dosage Contract Manufacturing due to its cost-effectiveness. The Chinese market for this type of manufacturing held over 50% of the market share in East Asia in 2023. Pharmaceutical manufacturing outsourcing is experiencing rapid growth in Asia, and Chinese CMOs have become preferred outsourcing partners for several reasons.
These include improved regulatory oversight and adherence to Current Good Manufacturing Practices (CGMP) standards, a skilled Chinese workforce, and effective cost containment strategies. These factors are expected to drive the growth of the oral solid dosage contract manufacturing industry in China in the years to come.

Competitive Analysis

Companies are expanding their manufacturing units to meet the growing demand in the pharmaceutical manufacturing sector. Key providers have also pursued acquisitions and expansions to consolidate their market presence.

Key Companies Profiled

  • Recipharm
  • Aenova Holding
  • Catalent
  • AbbVie
  • Patheon N.V. (Thermo Fisher Scientific)
  • NextPharma
  • Capsugel (Lonza Group AG)
  • Aurobindo Pharma Limited
  • Siegfried AG
  • Piramal Pharma Solutions
  • Corden Pharma
  • Kremoint Pharma Pvt Ltd.
  • HERMES PHARMA GmbH
  • Medipaams India Private Limited
  • Alpex Pharma
  • Abaris Healthcare Pvt Ltd
  • Ardena Holdings N.V
  • Aphena Pharma Solutions
  • Actiza Pharmaceutical Private Limited
  • Sunwin Healthcare PVT. LTD
  • Saffron Medicare PVT. LTD
  • Kosher Pharmaceuticals
  • Dr. Reddy’s Lab
  • GlaxoSmithKline Plc
  • Boehringer Ingelheim BioXcellence

Key Segments in Oral Solid Dosage Contract Manufacturing Industry Survey

Oral Solid Dosage Contract Manufacturing Market by Dosage Form:

  • Tablets
  • Conventional Release
  • Modified Release
  • Chewable Tablets
  • Effervescent Tablets
  • Capsules
  • Hard Gelatin Capsules
  • Soft Gelatin
  • Capsules/Softgels
  • Powders & Granules
  • Lozenges & Pastilles
  • Gummies

Oral Solid Dosage Contract Manufacturing Market by Mechanism:

  • Immediate Release
  • Delayed Release
  • Controlled Release

Oral Solid Dosage Contract Manufacturing Market by Application:

  • Drug Product Development
  • Fill & Finish Product Manufacturing
  • Packaging /Labelling
  • Others

Oral Solid Dosage Contract Manufacturing Market by End User:

  • Big Pharma/Biotech Companies
  • Smalls & Medium-size Pharma/Biotech Companies
  • Emerging/virtual Pharma Companies
  • Nutraceutical Companies

Oral Solid Dosage Contract Manufacturing Market by Region:

  • North America Oral Solid Dosage Contract Manufacturing Market
  • Latin America Oral Solid Dosage Contract Manufacturing Market
  • Europe Oral Solid Dosage Contract Manufacturing Market
  • South Asia Oral Solid Dosage Contract Manufacturing Market
  • East Asia Oral Solid Dosage Contract Manufacturing Market
  • Oceania Oral Solid Dosage Contract Manufacturing Market
  • Middle East & Africa Oral Solid Dosage Contract Manufacturing Market


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Oral Solid Dosage Contract Manufacturing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Oral Solid Dosage Contract Manufacturing Market Outlook, 2018 - 2031
3.1. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Tablets
3.1.1.1.1. Conventional Release
3.1.1.1.2. Modified Release
3.1.1.1.3. Chewable Tablets
3.1.1.1.4. Effervescent Tablets
3.1.1.2. Capsules
3.1.1.2.1. Hard Gelatin Capsules
3.1.1.2.2. Soft Gelatin
3.1.1.3. Capsules/Softgels
3.1.1.4. Powders & Granules
3.1.1.5. Lozenges & Pastilles
3.1.1.6. Gummies
3.2. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Immediate Release
3.2.1.2. Delayed Release
3.2.1.3. Controlled Release
3.3. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Drug Product Development
3.3.1.2. Fill & Finish Product Manufacturing
3.3.1.3. Packaging /Labelling
3.3.1.4. Others
3.4. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Big Pharma/Biotech Companies
3.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
3.4.1.3. Emerging/virtual Pharma Companies
3.4.1.4. Nutraceutical Companies
3.5. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Oral Solid Dosage Contract Manufacturing Market Outlook, 2018 - 2031
4.1. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Tablets
4.1.1.1.1. Conventional Release
4.1.1.1.2. Modified Release
4.1.1.1.3. Chewable Tablets
4.1.1.1.4. Effervescent Tablets
4.1.1.2. Capsules
4.1.1.2.1. Hard Gelatin Capsules
4.1.1.2.2. Soft Gelatin
4.1.1.3. Capsules/Softgels
4.1.1.4. Powders & Granules
4.1.1.5. Lozenges & Pastilles
4.1.1.6. Gummies
4.2. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Immediate Release
4.2.1.2. Delayed Release
4.2.1.3. Controlled Release
4.3. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Drug Product Development
4.3.1.2. Fill & Finish Product Manufacturing
4.3.1.3. Packaging /Labelling
4.3.1.4. Others
4.4. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Big Pharma/Biotech Companies
4.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
4.4.1.3. Emerging/virtual Pharma Companies
4.4.1.4. Nutraceutical Companies
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, 2018 - 2031
5.1. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Tablets
5.1.1.1.1. Conventional Release
5.1.1.1.2. Modified Release
5.1.1.1.3. Chewable Tablets
5.1.1.1.4. Effervescent Tablets
5.1.1.2. Capsules
5.1.1.2.1. Hard Gelatin Capsules
5.1.1.2.2. Soft Gelatin
5.1.1.3. Capsules/Softgels
5.1.1.4. Powders & Granules
5.1.1.5. Lozenges & Pastilles
5.1.1.6. Gummies
5.2. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Immediate Release
5.2.1.2. Delayed Release
5.2.1.3. Controlled Release
5.3. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Drug Product Development
5.3.1.2. Fill & Finish Product Manufacturing
5.3.1.3. Packaging /Labelling
5.3.1.4. Others
5.4. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Big Pharma/Biotech Companies
5.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
5.4.1.3. Emerging/virtual Pharma Companies
5.4.1.4. Nutraceutical Companies
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.9. France Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.10. France Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
5.5.1.11. France Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
5.5.1.12. France Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.17. Turkey Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.18. Turkey Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
5.5.1.19. Turkey Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
5.5.1.20. Turkey Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, 2018 - 2031
6.1. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Tablets
6.1.1.1.1. Conventional Release
6.1.1.1.2. Modified Release
6.1.1.1.3. Chewable Tablets
6.1.1.1.4. Effervescent Tablets
6.1.1.2. Capsules
6.1.1.2.1. Hard Gelatin Capsules
6.1.1.2.2. Soft Gelatin
6.1.1.3. Capsules/Softgels
6.1.1.4. Powders & Granules
6.1.1.5. Lozenges & Pastilles
6.1.1.6. Gummies
6.2. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Immediate Release
6.2.1.2. Delayed Release
6.2.1.3. Controlled Release
6.3. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Drug Product Development
6.3.1.2. Fill & Finish Product Manufacturing
6.3.1.3. Packaging /Labelling
6.3.1.4. Others
6.4. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Big Pharma/Biotech Companies
6.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
6.4.1.3. Emerging/virtual Pharma Companies
6.4.1.4. Nutraceutical Companies
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
6.5.1.4. China Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.13. India Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.14. India Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
6.5.1.16. India Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, 2018 - 2031
7.1. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Tablets
7.1.1.1.1. Conventional Release
7.1.1.1.2. Modified Release
7.1.1.1.3. Chewable Tablets
7.1.1.1.4. Effervescent Tablets
7.1.1.2. Capsules
7.1.1.2.1. Hard Gelatin Capsules
7.1.1.2.2. Soft Gelatin
7.1.1.3. Capsules/Softgels
7.1.1.4. Powders & Granules
7.1.1.5. Lozenges & Pastilles
7.1.1.6. Gummies
7.2. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Immediate Release
7.2.1.2. Delayed Release
7.2.1.3. Controlled Release
7.3. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Drug Product Development
7.3.1.2. Fill & Finish Product Manufacturing
7.3.1.3. Packaging /Labelling
7.3.1.4. Others
7.4. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Big Pharma/Biotech Companies
7.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
7.4.1.3. Emerging/virtual Pharma Companies
7.4.1.4. Nutraceutical Companies
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, 2018 - 2031
8.1. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Tablets
8.1.1.1.1. Conventional Release
8.1.1.1.2. Modified Release
8.1.1.1.3. Chewable Tablets
8.1.1.1.4. Effervescent Tablets
8.1.1.2. Capsules
8.1.1.2.1. Hard Gelatin Capsules
8.1.1.2.2. Soft Gelatin
8.1.1.3. Capsules/Softgels
8.1.1.4. Powders & Granules
8.1.1.5. Lozenges & Pastilles
8.1.1.6. Gummies
8.2. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Immediate Release
8.2.1.2. Delayed Release
8.2.1.3. Controlled Release
8.3. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Drug Product Development
8.3.1.2. Fill & Finish Product Manufacturing
8.3.1.3. Packaging /Labelling
8.3.1.4. Others
8.4. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Big Pharma/Biotech Companies
8.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
8.4.1.3. Emerging/virtual Pharma Companies
8.4.1.4. Nutraceutical Companies
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Application Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Recipharm
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Aenova Holding
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Catalent
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. AbbVie
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Patheon N.V. (Thermo Fisher Scientific)
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. NextPharma
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Capsugel (Lonza Group AG)
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Aurobindo Pharma Limited
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Siegfried AG
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Piramal Pharma Solutions
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Corden Pharma
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Kremoint Pharma Pvt Ltd.
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. HERMES PHARMA GmbH
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Medipaams India Private Limited
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. Alpex Pharma
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
9.4.16. Abaris Healthcare Pvt Ltd
9.4.16.1. Company Overview
9.4.16.2. Product Portfolio
9.4.16.3. Financial Overview
9.4.16.4. Business Strategies and Development
9.4.17. Ardena Holdings N.V
9.4.17.1. Company Overview
9.4.17.2. Product Portfolio
9.4.17.3. Financial Overview
9.4.17.4. Business Strategies and Development
9.4.18. Aphena Pharma Solutions
9.4.18.1. Company Overview
9.4.18.2. Product Portfolio
9.4.18.3. Financial Overview
9.4.18.4. Business Strategies and Development
9.4.19. Actiza Pharmaceutical Private Limited
9.4.19.1. Company Overview
9.4.19.2. Product Portfolio
9.4.19.3. Financial Overview
9.4.19.4. Business Strategies and Development
9.4.20. Sunwin Healthcare PVT. LTD
9.4.20.1. Company Overview
9.4.20.2. Product Portfolio
9.4.20.3. Financial Overview
9.4.20.4. Business Strategies and Development
9.4.21. Saffron Medicare PVT. LTD
9.4.21.1. Company Overview
9.4.21.2. Product Portfolio
9.4.21.3. Financial Overview
9.4.21.4. Business Strategies and Development
9.4.22. Dr Reddy’s Lab
9.4.22.1. Company Overview
9.4.22.2. Product Portfolio
9.4.22.3. Financial Overview
9.4.22.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Recipharm
  • Aenova Holding
  • Catalent
  • AbbVie
  • Patheon N.V. (Thermo Fisher Scientific)
  • NextPharma
  • Capsugel (Lonza Group AG)
  • Aurobindo Pharma Limited
  • Siegfried AG
  • Piramal Pharma Solutions
  • Corden Pharma
  • Kremoint Pharma Pvt Ltd.
  • HERMES PHARMA GmbH
  • Medipaams India Private Limited
  • Alpex Pharma
  • Abaris Healthcare Pvt Ltd
  • Ardena Holdings N.V
  • Aphena Pharma Solutions
  • Actiza Pharmaceutical Private Limited
  • Sunwin Healthcare PVT. LTD
  • Saffron Medicare PVT. LTD
  • Dr Reddy’s Lab

Methodology

Loading
LOADING...

Related Topics

Related Reports

Oral Solid Dosage Contract Manufacturing Market by Product Type, by Mechanism, by End-User, and By Region - Product Image

Oral Solid Dosage Contract Manufacturing Market by Product Type, by Mechanism, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Global Market Report 2024 - Product Image

Oral Solid Dosage Contract Manufacturing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market by Product, Mechanism, End-User - Global Forecast 2025-2030 - Product Image

Oral Solid Dosage Contract Manufacturing Market by Product, Mechanism, End-User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Tablets, Capsules, Powders, Granules), Mechanism, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Tablets, Capsules, Powders, Granules), Mechanism, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 193 Pages
  • Global
From
Global High Potency API Contract Manufacturing Market by Product, by Synthesis, by Application, by Dosage Form, by End-User, and By Region - Product Image

Global High Potency API Contract Manufacturing Market by Product, by Synthesis, by Application, by Dosage Form, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.